Naason Science
Naason Science
  • Home
  • CRO Services
    • Preclinical Research
    • Histology Services
    • CNS Models
    • Pain Models
    • Cardiovascular Models
    • Ophthalmology Models
    • Internal Disease Models
    • Psychiatric Models
    • Bone and Autoimmune
    • Safety and Toxicity
    • In Vitro
  • News
  • Virtual Gallery
  • Investors
  • Contact
  • More
    • Home
    • CRO Services
      • Preclinical Research
      • Histology Services
      • CNS Models
      • Pain Models
      • Cardiovascular Models
      • Ophthalmology Models
      • Internal Disease Models
      • Psychiatric Models
      • Bone and Autoimmune
      • Safety and Toxicity
      • In Vitro
    • News
    • Virtual Gallery
    • Investors
    • Contact
  • Sign In

  • My Account
  • Signed in as:

  • filler@godaddy.com


  • My Account
  • Sign out

Signed in as:

filler@godaddy.com

  • Home
  • CRO Services
    • Preclinical Research
    • Histology Services
    • CNS Models
    • Pain Models
    • Cardiovascular Models
    • Ophthalmology Models
    • Internal Disease Models
    • Psychiatric Models
    • Bone and Autoimmune
    • Safety and Toxicity
    • In Vitro
  • News
  • Virtual Gallery
  • Investors
  • Contact

Account


  • My Account
  • Sign out


  • Sign In
  • My Account

Investor relations

Naason Science’s notice of new stock issuance

신주발행 통지서

2024년 7월 29일


당사는 2024년 7월 16일 임시주주총회결의를 통해 제3자배정에 의한 

신주발행을 결의하였는 바, 상법 제418조 제4항에 의거하여 아래와 같이 그 내용을 통지 드립니다.


- 아 래 -


1. 제3자배정에 의한 신주발행의 건

1) 신주의 종류와 수 : 기명식 상환전환우선주 94,562주

2) 신주의 발행가액 : 1주 금 21,150원

3) 납입기일 : 2024년 8월 13일

4) 신주식의 배정방법 : 정관 제 10조의 규정에 의한 제3자 배정


July 29, 2024


We wish to inform you that, by resolution of the  shareholders' meeting on July 16, 2024, we have decided to issue new shares through third-party allocation, as stipulated under Article 418, Paragraph 4 of the Commercial Act.


We hereby notify you of the details as follows.  


Issuance of new shares by third party allocation

1) Type and number of new shares: 94,562 shares of registered redeemable convertible preferred stock

2) Issuance of price of new shares: KRW 21,150 per share

3) Payment due date: August 13, 2024

4) Method of allocating new stocks: Third party allocation in accordance with Article 10 of the Articles of Incorporation


Please download the full announcement below.



Naason Notice of new stock issuance (pdf)Download

© 2017-2025 Naason Science Inc. All rights reserved.

  • Home
  • Preclinical Research
  • News
  • Areas of Expertise
  • Privacy & Terms
  • Contact

Powered by

Welcome to Naason Science website!

Our website uses cookies. By continuing to use this site, you accept our use of cookies.

DeclineAccept